331 related articles for article (PubMed ID: 27986554)
21. Finerenone Reduces Renal RORγt γδ T Cells and Protects against Cardiorenal Damage.
Luettges K; Bode M; Diemer JN; Schwanbeck J; Wirth EK; Klopfleisch R; Kappert K; Thiele A; Ritter D; Foryst-Ludwig A; Kolkhof P; Wenzel UO; Kintscher U
Am J Nephrol; 2022; 53(7):552-564. PubMed ID: 35675794
[TBL] [Abstract][Full Text] [Related]
22. Reversal of cardiac, vascular, and renal dysfunction by non-quinazoline α1-adrenolytics in DOCA-salt hypertensive rats: a comparison with prazosin, a quinazoline-based α1-adrenoceptor antagonist.
Kubacka M; Zadrożna M; Nowak B; Kotańska M; Filipek B; Waszkielewicz AM; Marona H; Mogilski S
Hypertens Res; 2019 Aug; 42(8):1125-1141. PubMed ID: 30872813
[TBL] [Abstract][Full Text] [Related]
23. Resting Afferent Renal Nerve Discharge and Renal Inflammation: Elucidating the Role of Afferent and Efferent Renal Nerves in Deoxycorticosterone Acetate Salt Hypertension.
Banek CT; Knuepfer MM; Foss JD; Fiege JK; Asirvatham-Jeyaraj N; Van Helden D; Shimizu Y; Osborn JW
Hypertension; 2016 Dec; 68(6):1415-1423. PubMed ID: 27698066
[TBL] [Abstract][Full Text] [Related]
24. Heme arginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension.
Ndisang JF; Jadhav A
J Pharmacol Exp Ther; 2010 Jul; 334(1):87-98. PubMed ID: 20392817
[TBL] [Abstract][Full Text] [Related]
25. Tranilast attenuates myocardial fibrosis in association with suppression of monocyte/macrophage infiltration in DOCA/salt hypertensive rats.
Kagitani S; Ueno H; Hirade S; Takahashi T; Takata M; Inoue H
J Hypertens; 2004 May; 22(5):1007-15. PubMed ID: 15097242
[TBL] [Abstract][Full Text] [Related]
26. P2X7 deficiency attenuates hypertension and renal injury in deoxycorticosterone acetate-salt hypertension.
Ji X; Naito Y; Weng H; Endo K; Ma X; Iwai N
Am J Physiol Renal Physiol; 2012 Oct; 303(8):F1207-15. PubMed ID: 22859404
[TBL] [Abstract][Full Text] [Related]
27. Cytochrome P450 1B1 gene disruption minimizes deoxycorticosterone acetate-salt-induced hypertension and associated cardiac dysfunction and renal damage in mice.
Jennings BL; Estes AM; Anderson LJ; Fang XR; Yaghini FA; Fan Z; Gonzalez FJ; Campbell WB; Malik KU
Hypertension; 2012 Dec; 60(6):1510-6. PubMed ID: 23108654
[TBL] [Abstract][Full Text] [Related]
28. Role of angiotensin II type 1a receptor in renal injury induced by deoxycorticosterone acetate-salt hypertension.
Hisamichi M; Kamijo-Ikemori A; Sugaya T; Ichikawa D; Natsuki T; Hoshino S; Kimura K; Shibagaki Y
FASEB J; 2017 Jan; 31(1):72-84. PubMed ID: 27663860
[TBL] [Abstract][Full Text] [Related]
29. Brain endogenous angiotensin II receptor type 2 (AT2-R) protects against DOCA/salt-induced hypertension in female rats.
Dai SY; Peng W; Zhang YP; Li JD; Shen Y; Sun XF
J Neuroinflammation; 2015 Mar; 12():47. PubMed ID: 25885968
[TBL] [Abstract][Full Text] [Related]
30. Renal Inflammation in DOCA-Salt Hypertension.
Banek CT; Gauthier MM; Van Helden DA; Fink GD; Osborn JW
Hypertension; 2019 May; 73(5):1079-1086. PubMed ID: 30879356
[TBL] [Abstract][Full Text] [Related]
31. Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes.
Amador CA; Barrientos V; Peña J; Herrada AA; González M; Valdés S; Carrasco L; Alzamora R; Figueroa F; Kalergis AM; Michea L
Hypertension; 2014 Apr; 63(4):797-803. PubMed ID: 24420551
[TBL] [Abstract][Full Text] [Related]
32. Disruption of CXCR6 Ameliorates Kidney Inflammation and Fibrosis in Deoxycorticosterone Acetate/Salt Hypertension.
Wu Y; An C; Jin X; Hu Z; Wang Y
Sci Rep; 2020 Jan; 10(1):133. PubMed ID: 31924817
[TBL] [Abstract][Full Text] [Related]
33. Effects of omapatrilat on blood pressure and renal injury in L-NAME and L-NAME plus DOCA-treated rats.
Rodriguez-Gomez I; Wangensteen R; Atucha NM; O'Valle F; Del Moral RG; Garcia-Estañ J; Vargas F; Osuna A
Am J Hypertens; 2003 Jan; 16(1):33-8. PubMed ID: 12517680
[TBL] [Abstract][Full Text] [Related]
34. Reversal of vascular macrophage accumulation and hypertension by a CCR2 antagonist in deoxycorticosterone/salt-treated mice.
Chan CT; Moore JP; Budzyn K; Guida E; Diep H; Vinh A; Jones ES; Widdop RE; Armitage JA; Sakkal S; Ricardo SD; Sobey CG; Drummond GR
Hypertension; 2012 Nov; 60(5):1207-12. PubMed ID: 23033370
[TBL] [Abstract][Full Text] [Related]
35. Flax lignan concentrate reverses alterations in blood pressure, left ventricular functions, lipid profile and antioxidant status in DOCA-salt induced renal hypertension in rats.
Sawant SH; Bodhankar SL
Ren Fail; 2016; 38(3):411-23. PubMed ID: 26795298
[TBL] [Abstract][Full Text] [Related]
36. Sodium butyrate ameliorates deoxycorticosterone acetate/salt-induced hypertension and renal damage by inhibiting the MR/SGK1 pathway.
Wu C; Chen Z; Zhang L; Zhu Y; Deng M; Huang C; Liu Y; Zhu Q; Wang L
Hypertens Res; 2021 Feb; 44(2):168-178. PubMed ID: 32908237
[TBL] [Abstract][Full Text] [Related]
37. Protective effect of TRPV1 against renal fibrosis via inhibition of TGF-β/Smad signaling in DOCA-salt hypertension.
Wang Y; Wang DH
Mol Med; 2011; 17(11-12):1204-12. PubMed ID: 21792478
[TBL] [Abstract][Full Text] [Related]
38. Dual angiotensin-converting enzyme/neutral endopeptidase inhibition on cardiac and renal fibrosis and inflammation in DOCA-salt hypertensive rats.
Pu Q; Amiri F; Gannon P; Schiffrin EL
J Hypertens; 2005 Feb; 23(2):401-9. PubMed ID: 15662229
[TBL] [Abstract][Full Text] [Related]
39. [Role of chemokine receptor 2 in renal damage induced by deoxycorticosterone acetate-salt hypertension].
Sun M; Cui L; Liu WH; Gao Y; Shen S; Zhu MJ; Wang YP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):29-35. PubMed ID: 23469787
[TBL] [Abstract][Full Text] [Related]
40. Deficiency of the interleukin 17/23 axis accelerates renal injury in mice with deoxycorticosterone acetate+angiotensin ii-induced hypertension.
Krebs CF; Lange S; Niemann G; Rosendahl A; Lehners A; Meyer-Schwesinger C; Stahl RA; Benndorf RA; Velden J; Paust HJ; Panzer U; Ehmke H; Wenzel UO
Hypertension; 2014 Mar; 63(3):565-71. PubMed ID: 24366079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
